Evidence map›Paper›PMID 29382648›Full record

ReviewArchives of disease in childhood. Fetal and neonatal edition2018

Why are preterm newborns at increased risk of infection?

Amélie Collins, Jörn-Hendrik Weitkamp, James L Wynn

Registry-linked trialOpen access · greenAbstract readReview
In one paragraph

Review in Archives of disease in childhood. Fetal and neonatal edition, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05266664 (Preterm Immune System Development and Response to Immunization), which is not on this map. Cited by 145 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
145citing papers in PubMed, 5 pooled it
20.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05266664 unknown statusnot on this mapstarted 2022, after this paper: background citation

Preterm Immune System Development and Response to Immunization

TypeobservationalSponsorMaastricht University Medical CenterRan2022 to 2026Enrolled145ConditionsImmune System Disorder, Preterm, Vaccination Failure
3 · Its place in the literature

Who cites it

145 citing papers in PubMed, 5 syntheses or guidelines pooled it, 243 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

85 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Amélie CollinsDivision of Neonatology, Department of Pediatrics, Columbia University, New York City, New York, USA.
Jörn-Hendrik WeitkampDivision of Neonatology, Department of Pediatrics, Vanderbilt University, Nashville, Tennessee, USA.
James L WynnDivision of Neonatology, Department of Pediatrics, University of Florida, Gainesville, Florida, USA.ORCID http://orcid.org/0000-0001-7052-4836
Columbia University · USUniversity of Florida · USVanderbilt University · US

Funding

Microfluidic Assessment of Clinical Outcomes in Preterm NewbornsR01HD089939 · NICHD · UNIVERSITY OF FLORIDA · PI IRIMIA, DANIEL, MOLDAWER, LYLE L · 2017 to 2021
$3.3M
Modifiable Determinants of Mortality in Neonatal SepsisR01GM128452 · NIGMS · UNIVERSITY OF FLORIDA · PI WYNN, JAMES LAWRENCE · 2018 to 2022
$1.9M
The Role of the Inflammasome in Neonatal SepsisK08GM106143 · NIGMS · VANDERBILT UNIVERSITY · PI WYNN, JAMES LAWRENCE · 2013 to 2017
$875k
NICHD NIH HHS R01 HD089939NIGMS NIH HHS K08 GM106143NIGMS NIH HHS R01 GM128452
6 · The paper itself

Abstract

One in 10 newborns will be born before completion of 36 weeks' gestation (premature birth). Infection and sepsis in preterm infants remain a significant clinical problem that represents a substantial financial burden on the healthcare system. Many factors predispose premature infants for having the greatest risk of developing and succumbing to infection as compared with all other age groups across the age spectrum. It is clear that the immune system of preterm infants exhibits distinct, rather than simply deficient, function as compared with more mature and older humans and that the immune function in preterm infants contributes to infection risk. While no single review can cover all aspects of immune function in this population, we will discuss key aspects of preterm neonatal innate and adaptive immune function that place them at high risk for developing infections and sepsis, as well as sepsis-associated morbidity and mortality.

Indexed as

Adaptive ImmunityB-LymphocytesHumansImmunity, CellularImmunity, InnateImmunoglobulinsInfant, PrematureInfant, Premature, DiseasesInfectionsSepsisImmunoglobulinsimmunologyinfectious diseasesneonatologysepsis

Identifiers

PMID29382648
PMCPMC6013388
OpenAlexW2789824531

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.